Search
Search Constraints
You searched for: Author/Creator Couderq, Stephan- Couderq, Stephan [remove] 3
- Endocrinology -- Periodicals 2
- Periodicals 2
- 333.705 1
- 573.4 1
- 616.4 1
- AO adverse outcome -- AOP adverse outcome pathway -- ACR albumin-to-creatinine ratio -- AD androstenedione -- AhR aryl hydrocarbon receptor -- ALT alanine aminotransferase -- AMH anti-Müllerian hormone -- AP alkaline phosphatase -- AR androgen receptor -- AST aspartate aminotransferase -- BEX2 brain expressed X-linked 2 -- BDNF brain-derived neurotrophic factor -- BPA bisphenol A -- BRCA1 breast cancer 1 -- CaMKII calcium/calmodulin-dependent kinase II -- CMHS Canadian measures health survey -- COMT catechol O-methyltransferase -- CpG 5′—cytosine—phosphate—guanine—3′ -- CREB cAMP response element-binding protein -- CRP c-reactive protein -- DHEA-S dehydroepiandrosterone sulfate -- DHT dihydrotestosterone -- DNA deoxyribonucleic acid -- E1 estrone -- E2 17β-estradiol -- E3 estriol -- EDCs endocrine-disrupting chemicals -- ERR estrogen related receptor -- ER estrogen receptor -- FAI free androgen index -- FSH follicle stimulating hormone -- FT free testosterone -- FT3 free triiodothyronine -- FT4 free thyroxine -- GDNF glial cell-derived neurotrophic factor -- GnRH gonadotrophin releasing hormone -- GGT gamma glutamyl transpeptidase -- GSH glutathione, reduced form -- HbA1c glycated hemoglobin -- HBM human biomonitoring -- HBM4EU European Human Biomonitoring Initiative -- HDL-C high-density lipoprotein cholesterol -- HNE-MA 4-hydroxy-2-nonenal-mercapturic acid -- HOXA10 homeobox A10 -- HOMA-B homeostasis model assessment of beta-cell function -- HOMA-IR homeostasis model assessment for insulin resistance -- HP hypothalamus-pituitary -- HPA hypothalamus–pituitaryadrenal -- HPLC high performance liquid chromatography -- HPT hypothalamus-pituitary-thyroid -- hs-CRP high-sensitivity c-reactive protein -- IgE immunoglobulin E -- IL interleukin -- INHB inhibin B -- INSL3 insulin-like peptide 3 -- KE key event -- KiSS kisspeptin -- LD lactate dehydrogenase -- LDL-C low-density lipoprotein cholesterol -- LH luteinizing hormone -- LINE-1 long interspersed element-1 -- LTP long-term potentiation -- LTRs long terminal repeats -- MDA malondialdehyde -- MIE molecular initiating event -- MoA mode of action -- NHANES National Health and Nutrition Examination Survey -- NIS sodium/iodide symporter -- NMDARs glutamate N-methyl-D-aspartate receptors -- NRs nuclear receptors -- NRC National Research Council -- PCOS polycystic ovary syndrome -- PlGF placental growth factor -- PBMCs peripheral blood mononuclear cells -- PREG pregnenolone -- PRL prolactin -- PXR pregnane X receptor -- P4 progesterone -- RHs reproductive hormones -- RNA ribonucleic acid -- ROS reactive oxygen species -- sFlt1 soluble fms-like tyrosine kinase-1 -- SHBG sex hormone-binding globulin -- SP4 specific protein 4 -- STAT3 signal transducer and activator of transcription 3 -- SULT2A1 sulfotransferase family 2A member 1 -- TBA2-MDA thiobarbituric acid-malondialdehyde -- TC total cholesterol -- TG triglycerides -- THs thyroid hormones -- TNF-α tumor necrosis factor alpha -- TPOab thyroid peroxidase autoantibodies -- TSH thyroid-stimulating hormone -- TSLP thymic stromal lymphopoietin -- TSP50 testis-specific protease-like protein 50 -- TT total testosterone -- TT3 total triiodothyronine -- TT4 total thyroxine -- T2DM type 2 diabetes mellitus -- U.S. the United States of America -- WHO World Health Organization -- 8OHdG 8-hydroxy-2′-deoxyguanosine -- 8-isoprostane 8-iso-prostaglandin F2α 1
- Bisphenol A -- Bisphenol analogues -- Human biomonitoring -- Effect biomarker -- Adverse outcome pathway 1
- Cytology 1
- Cytology -- Periodicals 1
- Diabetes -- Periodicals 1